{"@context":"https:\/\/schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Phase 1, Open-Label Study of Autologous SIRPA-low Macrophages (SIRPant-M)  a cellular therapeutic product Administered by Intratumoral Injection Alone or in Combination with Focal External-Beam Radiotherapy in Participants with Relapsed or Refractory Non-Hodgkin’s Lymphoma","item":"https:\/\/www.regionalcancercare.org\/trials\/phase-1-open-label-study-of-autologous-sirpa-low-macrophages-sirpant-m-a-cellular-therapeutic-product-administered-by-intratumoral-injection-alone-or-in-combination-with-focal-external-beam-radiot\/#breadcrumbitem"}]}